The drug have benefits, but I am must say that it has its doubts . I would think that AFREEZA would have sold more than exubera especially with a big pharma on their coat tail.. In my mind, if you inhale something then you are putting risk to the lungs and it eliminates many users. Parents will not let children inhale, smokers can have respitory problems . I would think that would at least be in the hundreds of millions by now. I remembered buying this in the $1.60's and dumping at $8.39 and never touched it again. Good luck to all, but it looks really gloomy if sales doesn't pick up.
Short traders have controlled this stock for a long time at will, now they are facing big pharma's partnership and financial collaborations. Unexpectedly PPHM can get monetary milestones upfront since there are two potential bidders of Bavi. This makes the game in the Cancer arena much interesting with good results. We shall see, but any dips will be a blessing. Go for it and nothing to loose if two big Pharma's are bidding.